Adherence with inhibitor testing recommendations from the NBDF MASAC
| ED . | Participants with at least this number of EDs, N . | Expected number of inhibitor tests, N . | Participants with completion of recommended inhibitor testing∗ at this ED, n (%) . |
|---|---|---|---|
| 4 | 137 | 1 | 54 (39.42) |
| 7 | 127 | 2 | 34 (26.77) |
| 10 | 113 | 3 | 15 (13.27) |
| 13 | 110 | 4 | 10 (9.09) |
| 16 | 102 | 5 | 10 (9.80) |
| 19 | 98 | 6 | 8 (8.16) |
| 22 | 96 | 7 | 6 (6.25) |
| ED . | Participants with at least this number of EDs, N . | Expected number of inhibitor tests, N . | Participants with completion of recommended inhibitor testing∗ at this ED, n (%) . |
|---|---|---|---|
| 4 | 137 | 1 | 54 (39.42) |
| 7 | 127 | 2 | 34 (26.77) |
| 10 | 113 | 3 | 15 (13.27) |
| 13 | 110 | 4 | 10 (9.09) |
| 16 | 102 | 5 | 10 (9.80) |
| 19 | 98 | 6 | 8 (8.16) |
| 22 | 96 | 7 | 6 (6.25) |
Expected number of tests at each ED is based on NBDF MASAC document 236: at least every third ED or every 3 months (whichever occurs sooner) until 20 EDs have been reached and then every 3 to 6 months until 150 EDs.